Maharastra, India

Rajesh Ramchandra Walavalkar

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Rajesh Ramchandra Walavalkar

Introduction

Rajesh Ramchandra Walavalkar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of two patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Walavalkar's latest patents include the "Rivaroxaban intermediate and preparation thereof" and the "Aldehyde derivative of substitute oxazolidinones." The first patent relates to a novel intermediate formula for rivaroxaban and outlines a process for its preparation. This invention involves treating the intermediate with 5-chlorothiophene carbonyl chloride to create rivaroxaban derivatives. The second patent focuses on a prodrug of a specific compound, which is aimed at treating thromboembolic disorders. This prodrug is chemically designated as 5-chloro-N-formyl-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide.

Career Highlights

Walavalkar is currently associated with Wanbury Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

He collaborates with talented coworkers such as Nitin Sharadchandra Pradhan and Nilesh Sudhir Patil, contributing to a dynamic team focused on advancing pharmaceutical research.

Conclusion

Rajesh Ramchandra Walavalkar's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving medical treatments. His work is a testament to the importance of research and development in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…